Nightstar Therapeutics Competitors and Similar CompaniesClear all

Nightstar Therapeutics's competitors and similar companies include Intellia Therapeutics, RD-Biotech, AnGes and CRISPR Therapeutics.

	Nightstar Therapeutics Nightstar Therapeutics (formerly known as NightstaRx) is a clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases.	Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.	RD-Biotech RD-Biotech is a biotechnology company that offers customized solutions in genomics, immunology, and cell engineering.	AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.	CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Founding Date	Founding Date 2013	Founding Date 2014	Founding Date 2002	Founding Date 1999	Founding Date 2013
Type	Type Subsidiary	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech clinical research healthtech	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations London, GB HQ Lexington, US	Locations Cambridge, US HQ	Locations Besançon, FR HQ Saint Genis Laval, FR	Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US	Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US
Employees	Employees 4774% increase	Employees 40323% decrease	Employees 613% increase	Employees 5562% decrease	Employees 393
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.7 b	Valuation ($) N/A	Valuation ($) 78.3 m	Valuation ($) 4.2 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $67.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ¥874.1m (FY, 2025)	Revenue (est.) $3.5m (FY, 2025)
Net income	Net income ($36.9m) (FY, 2018)	Net income ($412.7m) (FY, 2025)	Net income N/A	Net income (¥5.1b) (FY, 2025)	Net income ($581.6m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 99.6m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 127m